204 related articles for article (PubMed ID: 29282139)
1. Effective radiotherapeutic treatment intensification in patients with pancreatic cancer: higher doses alone, higher RBE or both?
Dreher C; Habermehl D; Jäkel O; Combs SE
Radiat Oncol; 2017 Dec; 12(1):203. PubMed ID: 29282139
[TBL] [Abstract][Full Text] [Related]
2. Worst case optimization for interfractional motion mitigation in carbon ion therapy of pancreatic cancer.
Steitz J; Naumann P; Ulrich S; Haefner MF; Sterzing F; Oelfke U; Bangert M
Radiat Oncol; 2016 Oct; 11(1):134. PubMed ID: 27717378
[TBL] [Abstract][Full Text] [Related]
3. Four-dimensional treatment planning in layer-stacking boost irradiation for carbon-ion pancreatic therapy.
Mori S; Shinoto M; Yamada S
Radiother Oncol; 2014 May; 111(2):258-63. PubMed ID: 24746568
[TBL] [Abstract][Full Text] [Related]
4. Gated carbon-ion scanning treatment for pancreatic tumour with field specific target volume and organs at risk.
Miki K; Mori S; Shiomi M; Yamada S
Phys Med; 2016 Dec; 32(12):1521-1528. PubMed ID: 27884463
[TBL] [Abstract][Full Text] [Related]
5. Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial.
Combs SE; Habermehl D; Kieser M; Dreher C; Werner J; Haselmann R; Jäkel O; Jäger D; Büchler MW; Debus J
BMC Cancer; 2013 Sep; 13():419. PubMed ID: 24034562
[TBL] [Abstract][Full Text] [Related]
6. Beam direction arrangement using a superconducting rotating gantry in carbon ion treatment for pancreatic cancer.
Koom WS; Mori S; Furuich W; Yamada S
Br J Radiol; 2019 Jun; 92(1098):20190101. PubMed ID: 30943057
[TBL] [Abstract][Full Text] [Related]
7. Commissioning of Helium Ion Therapy and the First Patient Treatment With Active Beam Delivery.
Tessonnier T; Ecker S; Besuglow J; Naumann J; Mein S; Longarino FK; Ellerbrock M; Ackermann B; Winter M; Brons S; Qubala A; Haberer T; Debus J; Jäkel O; Mairani A
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):935-948. PubMed ID: 36681200
[TBL] [Abstract][Full Text] [Related]
8. Planning strategies for inter-fractional robustness in pancreatic patients treated with scanned carbon therapy.
Batista V; Richter D; Combs SE; Jäkel O
Radiat Oncol; 2017 Jun; 12(1):94. PubMed ID: 28595643
[TBL] [Abstract][Full Text] [Related]
9. Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan.
Inaniwa T; Kanematsu N; Matsufuji N; Kanai T; Shirai T; Noda K; Tsuji H; Kamada T; Tsujii H
Phys Med Biol; 2015 Apr; 60(8):3271-86. PubMed ID: 25826534
[TBL] [Abstract][Full Text] [Related]
10. Adaptive planning based on single beam optimization in passive scattering carbon ion radiotherapy for patients with pancreatic cancer.
Li Y; Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Tashiro M; Nakano T; Ohno T
Radiat Oncol; 2021 Jun; 16(1):111. PubMed ID: 34147099
[TBL] [Abstract][Full Text] [Related]
11. Dose escalation study with respiratory-gated carbon-ion scanning radiotherapy using a simultaneous integrated boost for pancreatic cancer: simulation with four-dimensional computed tomography.
Kawashiro S; Mori S; Yamada S; Miki K; Nemoto K; Tsuji H; Kamada T
Br J Radiol; 2017 Apr; 90(1072):20160790. PubMed ID: 28181819
[TBL] [Abstract][Full Text] [Related]
12. Biophysical modeling and experimental validation of relative biological effectiveness (RBE) for
Mein S; Dokic I; Klein C; Tessonnier T; Böhlen TT; Magro G; Bauer J; Ferrari A; Parodi K; Haberer T; Debus J; Abdollahi A; Mairani A
Radiat Oncol; 2019 Jul; 14(1):123. PubMed ID: 31296232
[TBL] [Abstract][Full Text] [Related]
13. Effect of patient positioning on carbon-ion therapy planned dose distribution to pancreatic tumors and organs at risk.
Miki K; Fukahori M; Kumagai M; Yamada S; Mori S
Phys Med; 2017 Jan; 33():38-46. PubMed ID: 28003135
[TBL] [Abstract][Full Text] [Related]
14. Optimization of carbon ion and proton treatment plans using the raster-scanning technique for patients with unresectable pancreatic cancer.
Dreher C; Habermehl D; Ecker S; Brons S; El-Shafie R; Jäkel O; Debus J; Combs SE
Radiat Oncol; 2015 Nov; 10():237. PubMed ID: 26590103
[TBL] [Abstract][Full Text] [Related]
15. A trichrome beam model for biological dose calculation in scanned carbon-ion radiotherapy treatment planning.
Inaniwa T; Kanematsu N
Phys Med Biol; 2015 Jan; 60(1):437-51. PubMed ID: 25658007
[TBL] [Abstract][Full Text] [Related]
16. Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study.
Liermann J; Naumann P; Hommertgen A; Pohl M; Kieser M; Debus J; Herfarth K
BMC Cancer; 2020 Oct; 20(1):947. PubMed ID: 33004046
[TBL] [Abstract][Full Text] [Related]
17. Robustness of daily dose for each beam angle and accumulated dose for inter-fractional anatomical changes in passive carbon-ion radiotherapy for pancreatic cancer: Bone matching versus tumor matching.
Kubota Y; Okamoto M; Shiba S; Okazaki S; Matsui T; Li Y; Itabashi Y; Sakai M; Kubo N; Tsuda K; Ohno T; Nakano T
Radiother Oncol; 2021 Apr; 157():85-92. PubMed ID: 33515667
[TBL] [Abstract][Full Text] [Related]
18. Effects of beam interruption time on tumor control probability in single-fractionated carbon-ion radiotherapy for non-small cell lung cancer.
Inaniwa T; Kanematsu N; Suzuki M; Hawkins RB
Phys Med Biol; 2015 May; 60(10):4105-21. PubMed ID: 25933161
[TBL] [Abstract][Full Text] [Related]
19. Comparison of carbon-ion passive and scanning irradiation for pancreatic cancer.
Shiomi M; Mori S; Shinoto M; Nakayama Y; Kamada T; Yamada S
Radiother Oncol; 2016 May; 119(2):326-30. PubMed ID: 27262617
[TBL] [Abstract][Full Text] [Related]
20. Temporal lobe reactions after carbon ion radiation therapy: comparison of relative biological effectiveness-weighted tolerance doses predicted by local effect models I and IV.
Gillmann C; Jäkel O; Schlampp I; Karger CP
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1136-41. PubMed ID: 24661667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
